Market closed
Assembly Biosciences Inc./$ASMB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
Ticker
$ASMB
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
73
Website
ASMB Metrics
BasicAdvanced
$79M
-
-$6.69
0.63
-
Price and volume
Market cap
$79M
Beta
0.63
52-week high
$13.37
52-week low
$7.75
Average daily volume
30K
Financial strength
Current ratio
2.416
Quick ratio
2.353
Long term debt to equity
7.878
Total debt to equity
9.26
Management effectiveness
Return on assets (TTM)
-22.18%
Return on equity (TTM)
-107.92%
Valuation
Price to revenue (TTM)
2.217
Price to book
2.35
Price to tangible book (TTM)
2.35
Price to free cash flow (TTM)
-1.236
Growth
Revenue change (TTM)
298.16%
Earnings per share change (TTM)
-49.98%
3-year revenue growth (CAGR)
65.83%
3-year earnings per share growth (CAGR)
-42.93%
ASMB News
AllArticlesVideos
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress
GlobeNewsWire·3 weeks ago
Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Assembly Biosciences Inc. stock?
Assembly Biosciences Inc. (ASMB) has a market cap of $79M as of April 26, 2025.
What is the P/E ratio for Assembly Biosciences Inc. stock?
The price to earnings (P/E) ratio for Assembly Biosciences Inc. (ASMB) stock is 0 as of April 26, 2025.
Does Assembly Biosciences Inc. stock pay dividends?
No, Assembly Biosciences Inc. (ASMB) stock does not pay dividends to its shareholders as of April 26, 2025.
When is the next Assembly Biosciences Inc. dividend payment date?
Assembly Biosciences Inc. (ASMB) stock does not pay dividends to its shareholders.
What is the beta indicator for Assembly Biosciences Inc.?
Assembly Biosciences Inc. (ASMB) has a beta rating of 0.63. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.